Related references
Note: Only part of the references are listed.Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival
P. H. Sugarbaker et al.
EJSO (2017)
The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma
Aatur D. Singhi et al.
MODERN PATHOLOGY (2016)
New Markers for Separating Benign From Malignant Mesothelial Proliferations Are We There Yet?
Andrew Churg et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition
Maria E. R. Garcia-Rendueles et al.
CANCER DISCOVERY (2015)
Prominent In Situ Component in a Pleural Malignant Mesothelioma
Francesca Bono et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2015)
p16 FISH Deletion in Surface Epithelial Mesothelial Proliferations Is Predictive of Underlying Invasive Mesothelioma
Harry Hwang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers
Douglas W. Henderson et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
The Separation of Benign and Malignant Mesothelial Proliferations
Andrew Churg et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas
Simion Chiosea et al.
MODERN PATHOLOGY (2008)
Chromosomal alterations in early stages of malignant mesotheliomas
F Simon et al.
VIRCHOWS ARCHIV (2005)
Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf
YA Wang et al.
ONCOGENE (2005)
Share Paper
